The use of ultrasound-guided vacuum-assisted breast biopsy devices should help reduce the need for rebiopsies, researchers in a large multicenter trial reported Monday. The study covered five centers in Canada, the U.S., and Europe and included
The use of ultrasound-guided vacuum-assisted breast biopsy devices should help reduce the need for rebiopsies, researchers in a large multicenter trial reported Monday.
The study covered five centers in Canada, the U.S., and Europe and included results from 13,582 ultrasound-guided biopsies conducted between 1999 and 2003. There were 123 rebiopsies.
The rebiopsy rate ranged from 0.2% to 3.21%, depending on the center. The most common reason for rebiopsy was radiological-pathological discordance. The rebiopsy resulted in a diagnostic change 61% of the time, and in 17% of the cases, led to a diagnosis of cancers missed in the first biopsy.
The single biggest factor influencing the rebiopsy rate was the use of a 14-gauge core needle biopsy device, according to the study. Other factors were dense breasts and BI-RADS ratings of four or five. The size of the lesion was not a significant factor.
Other studies have examined the rebiopsy question but, with smaller patient numbers, did not to have the statistical power of the current study, said presenter N. Duchesne of the University of Ottawa.
Although a 14-gauge biopsy device is less expensive than a vacuum-assisted device, the findings suggested a need for wider use of the vacuum assisted device, Duchesne said.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.